DK0723552T3 - Oligopeptider afledt af fragmenter af C-reaktivt protein - Google Patents

Oligopeptider afledt af fragmenter af C-reaktivt protein

Info

Publication number
DK0723552T3
DK0723552T3 DK94916966T DK94916966T DK0723552T3 DK 0723552 T3 DK0723552 T3 DK 0723552T3 DK 94916966 T DK94916966 T DK 94916966T DK 94916966 T DK94916966 T DK 94916966T DK 0723552 T3 DK0723552 T3 DK 0723552T3
Authority
DK
Denmark
Prior art keywords
fragments
pct
reactive protein
oligopeptides derived
derived
Prior art date
Application number
DK94916966T
Other languages
English (en)
Inventor
Massimo Pinori
Patrizia Caretto
Flavio Leoni
Fabrizio Marcucci
Gianni Gromo
Paolo Mascagni
Silvana Cappelletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Application granted granted Critical
Publication of DK0723552T3 publication Critical patent/DK0723552T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737C-reactive protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94916966T 1993-10-12 1994-05-16 Oligopeptider afledt af fragmenter af C-reaktivt protein DK0723552T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
PCT/EP1994/001574 WO1995010531A1 (en) 1993-10-12 1994-05-16 Oligopeptides derived from c-reactive protein fragments

Publications (1)

Publication Number Publication Date
DK0723552T3 true DK0723552T3 (da) 2003-02-24

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916966T DK0723552T3 (da) 1993-10-12 1994-05-16 Oligopeptider afledt af fragmenter af C-reaktivt protein

Country Status (19)

Country Link
US (1) US6057295A (da)
EP (1) EP0723552B1 (da)
JP (1) JP3221881B2 (da)
KR (1) KR100363408B1 (da)
CN (1) CN1041524C (da)
AT (1) ATE226591T1 (da)
AU (1) AU684511B2 (da)
CA (1) CA2173939C (da)
DE (1) DE69431603T2 (da)
DK (1) DK0723552T3 (da)
ES (1) ES2185652T3 (da)
FI (1) FI961584A (da)
HU (1) HUT75538A (da)
IL (1) IL109761A0 (da)
IT (1) IT1271486B (da)
NO (1) NO961423L (da)
PT (1) PT723552E (da)
WO (1) WO1995010531A1 (da)
ZA (1) ZA943610B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (en) * 2002-10-09 2004-04-14 3 D Gene Pharma Pyrolidine derivatives useful in treatment of hepatitis C virus infection
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
DK2526119T3 (da) 2010-01-19 2018-07-30 Harvard College Manipuleret opsonin til patogen detektering og behandling
CA2842321C (en) 2011-07-18 2022-05-03 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
EP2976642A4 (en) 2013-03-15 2016-09-21 Harvard College METHODS AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR CAPTURE OF A TARGET ENTITY
AU2014268603B2 (en) 2013-05-21 2018-03-22 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3083658B1 (en) 2013-12-18 2019-05-08 President and Fellows of Harvard College Crp capture/detection of gram positive bacteria
EP3331549B1 (en) 2015-08-06 2020-12-23 President and Fellows of Harvard College Improved microbe-binding molecules and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
DE3783280T2 (de) * 1986-07-16 1993-05-06 Eniricerche Spa Teilweise retro-invertierte analoge des tuftsin, methode zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
JP3221881B2 (ja) 2001-10-22
DE69431603T2 (de) 2003-03-13
FI961584A0 (fi) 1996-04-11
AU6844194A (en) 1995-05-04
AU684511B2 (en) 1997-12-18
CA2173939A1 (en) 1995-04-20
ZA943610B (en) 1995-01-25
HU9600934D0 (en) 1996-08-28
EP0723552A1 (en) 1996-07-31
IT1271486B (it) 1997-05-28
ITMI932154A0 (it) 1993-10-12
FI961584A (fi) 1996-04-11
NO961423D0 (no) 1996-04-11
JPH09503200A (ja) 1997-03-31
PT723552E (pt) 2003-02-28
CN1133048A (zh) 1996-10-09
ITMI932154A1 (it) 1995-04-12
WO1995010531A1 (en) 1995-04-20
ATE226591T1 (de) 2002-11-15
CA2173939C (en) 2002-08-27
EP0723552B1 (en) 2002-10-23
DE69431603D1 (de) 2002-11-28
HUT75538A (en) 1997-05-28
IL109761A0 (en) 1994-08-26
US6057295A (en) 2000-05-02
KR100363408B1 (ko) 2003-02-11
NO961423L (no) 1996-06-10
CN1041524C (zh) 1999-01-06
ES2185652T3 (es) 2003-05-01

Similar Documents

Publication Publication Date Title
CY1119263T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
BR0112111A (pt) Realce de respostas imunes mediadas por proteìna de fusão de anticorpo-citocina por tratamento combinado com agentes de realce de captação de imunocitocina
DK0733109T3 (da) BMP-12, BMP-13 og seneinducerende præparater dermed
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
DK0723552T3 (da) Oligopeptider afledt af fragmenter af C-reaktivt protein
IL145689A0 (en) Methods
PT1131408E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
WO2003027251A3 (en) Novel molecules of the pyrin domain protein family and uses thereof
DE69839943D1 (de) Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen
PT782630E (pt) Gene da doenca poliquistica do rim
EA200001127A1 (ru) Бактериальные феромоны и их использование
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
BR0108187A (pt) Moléculas trade e usos relacionados com as mesmas
ATE255594T1 (de) Hepatitis b inhibitoren
EA199801032A1 (ru) Белки zona pellucida для контрацепции